XPR1, key regulator of phosphate homeostasis and potential drug target for ovarian and lung cancer

Pascal Pannier, Amel Lebsir, Vincent Ogor, Elycia Calvet, Elodie Chastel, Stéphane D’Agostino, Loreley Calvet, Sukhvinder Sidhu, Anand Kumar, Alexey Rak, Emilia Puig Lombardi, Christophe Marcireau, Isabelle Meaux, Christophe Henry

Open source

DOI
10.1186/s12885-026-16624-9
Published
2026-07-29
Container
BMC Cancer
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-16624-9,
  title = {XPR1, key regulator of phosphate homeostasis and potential drug target for ovarian and lung cancer},
  author = {Pascal Pannier and Amel Lebsir and Vincent Ogor and Elycia Calvet and Elodie Chastel and Stéphane D’Agostino and Loreley Calvet and Sukhvinder Sidhu and Anand Kumar and Alexey Rak and Emilia Puig Lombardi and Christophe Marcireau and Isabelle Meaux and Christophe Henry},
  year = {2026},
  journal = {BMC Cancer},
  doi = {10.1186/s12885-026-16624-9},
  url = {https://doi.org/10.1186/s12885-026-16624-9}
}

RIS

TY  - JOUR
TI  - XPR1, key regulator of phosphate homeostasis and potential drug target for ovarian and lung cancer
AU  - Pascal Pannier
AU  - Amel Lebsir
AU  - Vincent Ogor
AU  - Elycia Calvet
AU  - Elodie Chastel
AU  - Stéphane D’Agostino
AU  - Loreley Calvet
AU  - Sukhvinder Sidhu
AU  - Anand Kumar
AU  - Alexey Rak
AU  - Emilia Puig Lombardi
AU  - Christophe Marcireau
AU  - Isabelle Meaux
AU  - Christophe Henry
PY  - 2026
JO  - BMC Cancer
DO  - 10.1186/s12885-026-16624-9
UR  - https://doi.org/10.1186/s12885-026-16624-9
ER  - 

APA

Pannier, P., Lebsir, A., Ogor, V., Calvet, E., Chastel, E., D’Agostino, S., Calvet, L., Sidhu, S., Kumar, A., Rak, A., Lombardi, E. P., Marcireau, C., Meaux, I., & Henry, C. (2026). XPR1, key regulator of phosphate homeostasis and potential drug target for ovarian and lung cancer. BMC Cancer. https://doi.org/10.1186/s12885-026-16624-9

Source records